The short version of CJC-1295 fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-02-15. Anything still debated is marked as such rather than presented as settled.
Reverse-phase high-performance liquid chromatography is the standard tool for purity assessment. The technique separates the target peptide from truncated or modified byproducts. Mass spectrometry confirms molecular weight and supports sequence verification. Electrospray ionization and matrix-assisted laser desorption are both used. Amino acid analysis provides an independent check on composition. Purity values are commonly reported as area percentage from the chromatogram. Residual trifluoroacetate and water content are also measured in many quality programs.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | Reverse-phase HPLC | Reported as area percentage |
| Identity confirmation | Mass spectrometry | Electrospray or laser desorption |
| Powder storage | Minus 20 degrees Celsius or lower | Dark and dry conditions |
| Solution storage | Two to eight degrees Celsius | Avoid repeated freeze-thaw |
| Appearance | White to off-white powder | Common lyophilized form |
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
==== Urquía Carreño expelled from the Supreme Council ==== On January 25, 2024, the High Chamber of the Scottish Rite voted unanimously to sanction Urquía Carreño, determining that the actions of the Grand Master were "punishable and intentional, producing a large-scale Masonic schism in the national territory, which endangers the proper functioning of the Supreme Council and the Treaty of Friendship and Mutual Recognition." Shortly afterward, the Supreme Council issued Decree 009/2024, in which they declared that Urquía Carreño was henceforth expulsed from the Scottish Rite, writing that his actions were: "a clear sign of betrayal by failing to take the oath and loyalty to the fundamental principles of this Supreme Council." In this decree, Viñas Alonso iterated that Mario Urquía never wanted to inform anyone about the scandal, but that he refused to take part in Mario Urquía's attempted coverup. This document was signed by José Ramón Viñas Alonso. The Supreme Council levied the charge that Urquía Carreño had consistently lied about the facts of the case, and had attempted to manipulate the narrative in a public manner, writing that Urquía Carreño: "has established a field and visceral attack against the Supreme Council to which he himself belongs...
=== Greece === In Greece, licensed physicians are eligible to apply for a position in a residency program. To be a licensed physician, one must finish a medical training program which in Greece lasts for six years. A one-year obligatory rural medical service (internship) is necessary to complete the residency training. Applications are made individually in the prefecture where the hospital is located, and the applicants are positioned on first-come, first-served basis. The duration of the residency programs varies between three and seven years.
=== 1995–2006: DNA identity testing === In 1995, Bio-Synthesis, Inc. introduced DNA identity testing to its broad range of molecular diagnostic services. Today, the DNA Identity Testing Center of BSI uses advanced techniques and automated systems to produce the most accurate DNA testing results allowed by current scientific technologies. The DNA Identity Testing Center has its own staff of scientific professionals whose focus is to ensure the quality and integrity of all tests and services. In 2000, Bio-Synthesis, Inc. perform the genetic analysis close to 500 Chinese nationals that were soliciting, under the right of abode, the right to move to Hong Kong by proving that their biological fathers were Hong Kong residents.
=== Hollow microneedles === Hollow MNs are designed with a hole at the tip and a hollow capacity that store drugs. Upon MNs insertion, the stored drug is directly injected into the dermis and this effectively facilitates the absorption of either large-molecular or large-dosage drug. Yet, a portion of the drug can leaked or become clogged, and may hinder the overall drug administration. Since the delivery of the drug depends on the flow rate of the microneedle, this type of array could become clogged by excessive swelling or flawed design. This design also increases the likelihood of buckling under the pressure and therefore failing to deliver any drugs.
==== Wars with Assyria and Babylonia ==== The Kingdom of Israel was conquered by the Neo-Assyrian Empire around 720 BCE. The records of Sargon II of Assyria indicate that he deported part of the population to Assyria. Some Israelites migrated to the southern kingdom of Judah, while those that remained in Samaria, concentrated mainly around Mount Gerizim, developed a new ethnic identity as Samaritans. Foreign groups were also settled by the Assyrians in the territories of the conquered kingdom. Research indicates that only a portion of the surviving Israelite population intermarried with Mesopotamian settlers. In their native Samaritan Hebrew, the Samaritans identify as "Israel", "B'nai Israel" or "Shamerim/Shomerim" (i.e. "Guardians/Keepers/Watchers"). Despite this, belief in the Ten Lost Tribes of Israel emerged because of the heavy assimilation faced by Samarian deportees. Towards the end of the same century, the Neo-Babylonian Empire emerged victorious over the Assyrians, leading to Judah's subjugation as a vassal state. In the early 6th century BC, a series of revolts in Judah prompted the Babylonian king Nebuchadnezzar II to lay siege to and destroy Jerusalem along with the First Temple, marking the kingdom's demise. Subsequently, a segment of the Judahite populace was exiled to Babylon in several waves. Judeans were progenitors of the Jewish people, who practised Second Temple Judaism during the Second Temple period.
Sources: en.wikipedia.org
While Cannon Gladiator 4 is destroyed by Deka Base Robo, Gyanjava escapes from the Kaijuki, only for Yaako to disable his Muscle Gear before Deka Red S.W.A.T. Mode deletes him. Gyanjava is voiced by Yoshinori Okamoto, who also portrays his human form. Yuilwerian Mime (ユイルワー星人ミーメ, Yuiruwā Seijin Mīme): A spotty-eyed stag beetle–themed criminal from Planet Yuilwer who invades young women's dreams to steal their souls and create a youth potion from them. After targeting Umeko and attempting to use a Kaijuki called Megaroria 2 (メガロリア2, Megaroria Tsū) to further her plans, she is deleted by Deka Yellow and Pink in their S.W.A.T. Modes while Megaroria 2 is destroyed by Deka Wing Robo. Mime is voiced by Michie Tomizawa (富沢 美智恵, Tomizawa Michie). Guirarkian Don Bianco (ギラーク星人ドン・ビアンコ, Girāku Seijin Donbianko): A white tiger–themed member of the Intergalactic Mafia from Planet Guirark, and rival of Don Blaco, who is attacked and killed by Jingi. Don Bianco is voiced by Daisuke Egawa (江川 大輔, Egawa Daisuke). Zabunian Don Blaco (ザブン星人ドン・ブラコ, Zabun Seijin Donburako): A lion-themed member of the Intergalactic Mafia from Planet Zabun, and rival of Don Bianco, who hires Jingi to kill Bianco, only to be killed by the assassin as well. Don Blaco is voiced by Shigenori Sōya (宗矢 樹頼, Sōya Shigenori).
Generative artificial intelligence has been applied across multiple industries for content creation and automation. In healthcare, generative models are used for drug discovery and the generation of synthetic medical data to train diagnostic systems. In finance, they are used for report drafting, data generation, and customer service automation. Media and entertainment industries use generative systems for tasks such as music composition, script development, and image or video generation. Researchers and policymakers have raised concerns regarding accuracy, misuse, and impacts on academic and professional work.
After around 8 weeks customised foot orthoses can offer short-term relief. Other treatments have little supportive evidence and studies. These include rest, massage, heat, ice, and calf-strengthening exercises, weight reduction in the overweight or obese, and nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen. NSAID use is common, but fails to resolve pain in 20% of people. Corticosteroid injections are sometimes used for cases resistant to more conservative measures. Tentative evidence supports their use for short-term pain relief up to one month (only). Comparative evidence suggests that short- and long-term treatment effects vary. Corticosteroid injections may provide greater short-term pain relief, but their benefits then fade. In contrast, therapies such as platelet-rich plasma (PRP) and ESWT are associated with improved pain and functional outcomes over longer follow-up periods. However, studies remain inconsistent, and evidence quality is limited by variability in study design, treatment protocols, and outcome measures. As a result, no single treatment is established as universally superior. Another treatment technique is plantar iontophoresis. This technique involves applying anti-inflammatory substances such as dexamethasone or acetic acid topically to the foot and transmitting these substances through the skin with an electric current. Some evidence supports the use of night splints for 1–3 months to relieve pain after six months.
The western brown snake (Pseudonaja nuchalis) is a highly venomous species of brown snake common throughout Western Australia. Its venom contains powerful neurotoxins, nephrotoxins and a procoagulant, although humans are not usually affected by the neurotoxins. The bite is usually painless and difficult to see due to their small fangs. Human symptoms of a Western Brown snake bite are headache, nausea/vomiting, abdominal pain, severe coagulopathy and sometimes, kidney damage. The LD50 in mice is 0.47 mg/kg and the average venom yield per bite is 18 mg (dry weight of milked venom) according to Meier and White (1995). The western brown snake can cause rapid death in humans by cardiac arrest, kidney failure, or cerebral hemorrhage. The envenomation rate is 20–40% and the untreated mortality rate is 10–20%.
Vestiges of British ties were removed piecemeal by the government over the decade following UDI, and replaced with symbols and terminology intended to be more uniquely Rhodesian. A silver "Liberty Bell", based on the bell of the same name in Philadelphia, was cast during 1966 and rung by the Prime Minister 12 times each year on Independence Day (the anniversary of UDI), with some in the press erroneously believing the number of chimes signifying the number of years since the declaration of independence. The Union Jack and Rhodesia's Commonwealth-style national flag—a defaced Sky Blue Ensign with the Union Jack in the canton—continued to fly over government buildings, military bases and other official locations until 11 November 1968, the third anniversary of UDI, when they were superseded by a new national flag: a green-white-green vertical triband, charged centrally with the Rhodesian coat of arms. The Union Jack continued to be ceremonially raised at Cecil Square in Salisbury on 12 September each year as part of the Pioneers' Day holiday, which marked the anniversary of the establishment of Salisbury (and, by extension, Rhodesia) in 1890. Since Elizabeth II was still the Rhodesian head of state in the eyes of Smith's administration until 1970, "God Save the Queen" remained the Rhodesian national anthem, and continued to accompany official occasions such as the opening of the Rhodesian parliament.
Sources: en.wikipedia.org
Brown adipose tissue activation improves glucose homeostasis and insulin sensitivity in humans suggesting that anyone with impaired insulin function might benefit from BAT activation; however, there is broader application given research showing even mildly elevated blood glucose in healthy non-diabetic humans is associated with damage over time of many organs such as eyes, tendons, endothelial/cardiovascular system and brain, and results in higher levels of damaging advanced glycation end products. Brown adipose tissue activation may play an important role in bone health and bone density. Brown adipose tissue activation through cold exposure increases adiponectin levels, just two hours of cold exposure resulted in a 70% increase in circulating adiponectin in adult men. Centenarians (both men and women) and their offspring have been found to have genetics that boost adiponectin, and they have higher circulating adiponectin, suggesting a link between longevity and adiponectin production. In addition, high concentrations of plasma adiponectin in centenarians was associated with favorable metabolic indicators, and with lower levels of C-reactive protein and E-selectin. Cold exposure increases circulating irisin. Irisin improves insulin sensitivity, increases bone quality and quantity, is involved in the building of lean muscle mass, and helps reduce obesity by converting white fat to brown fat, providing many of the same benefits of exercise.
The protein tropomyosin covers the myosin-binding sites of the actin molecules in the muscle cell. For a muscle cell to contract, tropomyosin must be moved to uncover the binding sites on the actin. Calcium ions bind with troponin C molecules (which are dispersed throughout the tropomyosin protein) and alter the structure of the tropomyosin, forcing it to reveal the cross-bridge binding site on the actin. The concentration of calcium within muscle cells is controlled by the sarcoplasmic reticulum, a unique form of endoplasmic reticulum in the sarcoplasm. Muscle cells are stimulated when a motor neuron releases the neurotransmitter acetylcholine, which travels across the neuromuscular junction (the synapse between the terminal button of the neuron and the muscle cell). Acetylcholine binds to a post-synaptic nicotinic acetylcholine receptor. A change in the receptor conformation allows an influx of sodium ions and initiation of a post-synaptic action potential. The action potential then travels along T-tubules (transverse tubules) until it reaches the sarcoplasmic reticulum. Here, the depolarized membrane activates voltage-gated L-type calcium channels, present in the plasma membrane. The L-type calcium channels are in close association with ryanodine receptors present on the sarcoplasmic reticulum. The inward flow of calcium from the L-type calcium channels activates ryanodine receptors to release calcium ions from the sarcoplasmic reticulum. This mechanism is called calcium-induced calcium release (CICR).
(For a renovation that began in 1999, the RATP, the Paris transportation authority, restored the entrances to two slightly different shades: at sites with a lot of vegetation, vert wagon ('train-car green'), the dark green used for Parisian public works at the turn of the 20th century, and at fully urban sites, a slightly bluer shade, vert allemand ('German green').) He designed standardized components, including railing cartouches incorporating the letter "M" and signs in his own distinctive lettering reading "Métropolitain" or, at narrow entrances, "Métro"; later the use of the lettering was extended to a holder for a system map and for advertising (porte-plan) with the station name above. In addition to speed (the first set of entrances were installed within six months of their design) and relatively low cost in manufacture and adaptation to different sizes and locations of entrances, all of this gave the system a stylistic identity.
=== Lectins === Lectin affinity chromatography is a form of affinity chromatography where lectins are used to separate components within the sample. Lectins, such as concanavalin A are proteins which can bind specific alpha-D-mannose and alpha-D-glucose carbohydrate molecules. Some common carbohydrate molecules that is used in lectin affinity chromatography are Con A-Sepharose and WGA-agarose. Another example of a lectin is wheat germ agglutinin which binds D-N-acetyl-glucosamine. The most common application is to separate glycoproteins from non-glycosylated proteins, or one glycoform from another glycoform. Although there are various ways to perform lectin affinity chromatography, the goal is extract a sugar ligand of the desired protein.
==== Economic impact on Denmark ==== By 2023, Novo Nordisk was the most valuable corporation in the European Union, worth more than US$500 billion, and accounted for almost all economic growth in Denmark. The large amounts of foreign currency earned by Novo Nordisk from Wegovy and Ozempic sales, when converted to Danish krone, have exerted upward pressure on the value of the krone, making it necessary for Danmarks Nationalbank to maintain lower interest rates than the European Central Bank. Poor clinical trial results published by Novo Nordisk in December 2024 contributed to a drop in the krone's value. Profits from Novo Nordisk result in increased Danish tax revenues and employment. Novo Nordisk added 3,500 jobs in Denmark in 2022, bringing the total in the country to 21,000 employees, out of 59,000 worldwide. As of February 2026, Novo Nordisk has a market capitalization of $220.42 billion.
Sources: en.wikipedia.org
The powder is normally held at minus twenty degrees Celsius or below. Light and moisture exposure should be minimized. Repeated warming and cooling cycles are avoided.
Reverse-phase high-performance liquid chromatography is used for purity. Mass spectrometry confirms molecular weight and sequence integrity. Amino acid analysis offers an additional compositional check.
Published stability data for dissolved material are limited and vary with conditions. Refrigerated solutions are generally used within a short period. The exact shelf life depends on concentration, buffer, and handling.
The version carrying the affinity complex bears a maleimide group that binds serum albumin, which extends its circulation time to several days. The version without it lacks this group and clears within roughly half an hour. The two are chemically related but behave very differently once in the body.